Paulino Tallón de Lara

5PUBLICATIONS
56CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Immunology not elsewhere classifiedInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Aug 20, 2025
Cancer-induced nerve injury promotes resistance to anti-PD-1 therapy.

Erez N Baruch, Frederico O Gleber-Netto, Priyadharsini Nagarajan

|Jul 18, 2024
Baseline biomarkers of efficacy and on-treatment immune-profile changes associated with bempegaldesleukin plus nivolumab.

Helen Gogas, Shruthi Ravimohan, Antara Datta

|Feb 04, 2021
CD39+PD-1+CD8+ T cells mediate metastatic dormancy in breast cancer.

Paulino Tallón de Lara, Héctor Castañón, Marijne Vermeer

|Jul 05, 2018
Eosinophils suppress Th1 responses and restrict bacterially induced gastrointestinal inflammation.

Isabelle C Arnold, Mariela Artola-Borán, Paulino Tallón de Lara

Pageof 1